a developer of therapeutics for Alzheimer's disease and other neurodegenerative disorders
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FGDTX | 25.64 | 0.02 | +0.08% |
Fidelity Advisor Gold M | |||
AZMIX | 15.87 | N/A | N/A |
Virtus NFJ Emerging Markets Value Ins | |||
FTHCX | 92.09 | -0.13 | -0.14% |
Fidelity Advisor Technology C | |||
GPGIX | 3.50 | -0.01 | -0.28% |
Grandeur Peak Global Opportunities Instl | |||
IRGSX | 10.53 | -0.04 | -0.38% |
VY® CBRE Global Real Estate S2 |
A.I.dvisor indicates that over the last year, ALEC has been loosely correlated with DNLI. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ALEC jumps, then DNLI could also see price increases.
Ticker / NAME | Correlation To ALEC | 1D Price Change % | ||
---|---|---|---|---|
ALEC | 100% | -5.58% | ||
DNLI - ALEC | 57% Loosely correlated | +0.33% | ||
NTLA - ALEC | 54% Loosely correlated | -7.15% | ||
BEAM - ALEC | 53% Loosely correlated | -3.16% | ||
RCKT - ALEC | 52% Loosely correlated | -0.91% | ||
EDIT - ALEC | 50% Loosely correlated | -2.82% | ||
More |